Previous Article
Molecular and Cellular Biology, July 2001, p. 4837-4846, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4837-4846.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cell-Specific Association and Shuttling of I
B
Provides a Mechanism for Nuclear NF-
B in B Lymphocytes
Winnie F.
Tam,
Weihong
Wang,
and
Ranjan
Sen*
Rosenstiel Basic Medical Sciences Research
Center and Department of Biology, Brandeis University, Waltham,
Massachusetts 02454
Received 20 December 2000/Returned for modification 18 February
2001/Accepted 9 April 2001
 |
ABSTRACT |
Mature B lymphocytes are unique in containing nuclear Rel proteins
prior to cell stimulation. This activity consists largely of p50-c-Rel
heterodimers, and its importance for B-cell function is exemplified by
reduced B-cell viability in several genetically altered mouse strains.
Here we suggest a mechanism for the cell specificity and the subunit
composition of constitutive B-cell NF-
B based on the observed
properties of Rel homo- and heterodimers and I
B
. We show that
c-Rel lacks a nuclear export sequence, making the removal of
c-Rel-containing complexes from the nucleus less efficient than removal
of p65-containing complexes. Second, the nuclear import potential of
p65 and c-Rel homodimers but not p50-associated heterodimers was
attenuated when they were complexed to I
B
, leading to a greater
propensity of heterodimers to be nuclear. We propose that subunit
composition of B-cell NF-
B reflects the inefficient retrieval of
p50-c-Rel heterodimers from the nucleus. Cell specificity may be a
consequence of c-Rel-I
B
complexes being present only in mature B
cells, which leads to nuclear c-Rel due to I
B
turnover and
shuttling of the complex.
 |
INTRODUCTION |
The Rel family of transcription
factors regulate inducible gene transcription (11, 34).
These proteins share an approximately 300 amino acid domain at the N
terminus, the Rel homology domain (RHD), which is used for
protein-protein interactions and DNA binding. Homo- or
heterodimerization between Rel family members is essential for DNA
binding and interactions with the regulatory I
B proteins which
inhibit DNA binding and localize Rel proteins to the cell cytoplasm. In
most cells, Rel proteins are located in the cell cytoplasm complexed to
one of three I
B proteins
I
B
, I
B
, or I
B
(15,
25, 28, 44). Upon cell stimulation, I
Bs are phosphorylated at
their N termini by I
B kinases, which targets them for
proteasome-mediated degradation. This leaves the Rel proteins free to
translocate to the nucleus and activate gene expression. Rel
protein-dependent gene expression must be strictly controlled, as
exemplified by the phenotype of I
B
-deficient mice (3,
24). These animals die soon after birth, presumably due to
aberrant gene activation. Thus, regulation of DNA binding and
subcellular distribution of Rel proteins by I
Bs is a critical aspect
of the biology of these transcription factors.
The three I
Bs retain Rel proteins in the cytoplasm by different
mechanisms. I
B
, but not I
B
or I
B
, contains a strong nuclear export sequence (NES), and cytoplasmic location of p65-RelA by
I
B
has been shown to require nuclear export via the exportin CRM1
(16, 19, 42). Specifically, inhibition of nuclear export by mutating the I
B
NES or affecting CRM1 function genetically or
pharmacologically leads to nuclear accumulation of p65-I
B
complexes (16, 19, 42). Based on such studies, the current model is that cytoplasmic localization by I
B
is a dynamic
process, with I
B
-containing complexes shuttling between the
nucleus and the cytoplasm. Presumably, the net cytoplasmic appearance
of these complexes occurs because the balance between nuclear entry and exit is tilted in favor of the latter.
In contrast, I
B
and I
B
localize Rel proteins to the
cytoplasm as effectively as I
B
but do not contain identifiable
NESs. We have shown that nuclear export is not involved in this process and suggested that cytoplasmic localization by I
B
and I
B
reflects sequestration of Rel proteins (43). That is,
Rel-I
B
(or -I
B
) complexes are cytoplasmic because they
never make it into the nucleus. Furthermore, even when nuclear
p65-I
B
complexes were created by sequential expression of p65
followed by I
B
, export of this complex to the cytoplasm was
inefficient (43). Shuttling of I
B
-associated
complexes but not I
B
-associated complexes implies that there is
residual nuclear localization sequence (NLS) activity in I
B
complexes. Our working model is that I
B
association must hide the
Rel NLSs more effectively.
Mature B lymphocytes are unique in containing nuclear Rel proteins
prior to cell stimulation. The constitutive nuclear activity consists
of p50-c-Rel heterodimers (13, 22, 27, 30), and its
importance for B-cell function is exemplified by the lower viability of
B cells from p50-deficient and xid mice, both of which have decreased
constitutive NF-
B (2, 7, 20, 21, 23, 38, 39, 41). In
c-Rel-deficient mice, p50-p65 (NF-
B) heterodimer levels are elevated
in splenic B cells, suggesting that lack of p50-c-Rel heterodimers
must be compensated for (10, 26). Moreover, B-cell
viability is severely decreased in p65-c-Rel double-deficient mice
(12). Several models have been proposed to explain the
presence of nuclear NF-
B in B cells, such as increased turnover rate
of I
B
in WEHI 231 cells (29) and protection of
nuclear NF-
B by I
B
(36). Miyamoto and colleagues
have provided much of the support for the turnover model, in particular the recent demonstration that intracellular calcium controls I
B
degradation in mature B cells (9, 31, 40). However, the importance of I
B
half-life for constitutive nuclear NF-
B has not been directly demonstrated. Indeed, there is some evidence that
I
B
is not turned over as fast in immunoglobulin G (IgG)-positive B cells, yet there is constitutive NF-
B in the nucleus
(6). Finally, it is not clear why the constitutive
DNA-binding activity is largely composed of p50-c-Rel heterodimers.
In this paper we show that p50-c-Rel heterodimers have a greater
propensity to be nuclear than p50-p65 heterodimers or either homodimer
alone. Two properties of Rel and I
B proteins dictate this
preference. First, the NLSs of p65 and c-Rel homodimers are attenuated
by association with I
B
, while p50 provides a strong NLS and
thereby increases nuclear import of heterodimers. Second, c-Rel does
not contain a nuclear export sequence like p65; therefore, c-Rel-containing complexes are exported out of the nucleus less efficiently. We propose that the subunit composition of B-cell NF-
B
reflects the inefficient retrieval of p50-c-Rel heterodimers from the
nucleus. The question of retrieval only arises in B cells because c-Rel
is sequestered in the cytoplasm of pre-B cells and non-B cells by
association with I
B
. B-cell-specific association of c-Rel with
I
B
may further increase nuclear c-Rel because of I
B
turnover. Thus, the presence of constitutive "NF-
B" in B-cell
nuclei is the dynamic consequence of the properties of Rel and I
B proteins.
 |
MATERIALS AND METHODS |
Cell lines and strains.
D5h3 T hybridoma cells, WEHI-231
(immature B) cells, and DC27 (mature T) cells were grown in Dulbecco's
modified Eagle's medium (DMEM) (Gibco-BRL, New York, N.Y.)
supplemented with 10% heat-inactivated fetal bovine serum, 50 µM
-mercaptoethanol, 50 U of penicillin per ml, and 50 µg of
streptomycin per ml. A20 (mature B) cells, 70Z (pre-B) cells, M12
(mature B) cells, 22D6 (pre-B) cells, 38B9 (pre-B) cells, and 3A9
(mature T) cells were grown in RPMI 1640 medium (Gibco-BRL) with 10%
heat-inactivated fetal bovine serum and the above supplements. COS
cells were cultured in DMEM with 10% newborn calf serum and the above
antibiotics. BOSC23 (human kidney epithelial cells) were maintained in
DMEM with 10% heat-inactivated fetal bovine serum and antibiotics.
Splenic primary B cells were made by positively selecting mouse spleen
cell suspensions using CD19 MicroBeads and MiniMACs with an MS
column (Miltenyi Biotec). The sorted cells were then analyzed by
flow cytometry, and over 95% of cells were CD19 positive. For splenic
T cells, single-cell suspensions of mouse spleen cells were incubated
with concanvalin A (4 µg/ml) (CalBiochem) for 3 days. Cells were then
washed to remove concanavalin A and cultured in the presence of
recombinant human interleukin-2 (IL-2) (50 U/ml) (BD Transduction
Laboratories) for 7 days. Over 95% of T cells were T-cell
receptor-beta positive by flow cytometry.
Plasmids.
EGFP-p65 and pCDNA3.HA-I
B
have been
described previously (42). pCDNA3.HA-I
B
LIL3A49(NESn)
and HA-I
B
NESnc were made by PCR using fragments from
pGFP-I
B
NESc and pGFP-I
B
NESc-LIL3A49 (42) with
a hemagglutinin (HA) tag containing 5' primer and 3' primer. The
products were cloned into BamHI and EcoRI sites of pCDNA3 vector (Invitrogen Corporation). EGFP-p65(RHD) and
EGFP-p65(364) contain mouse p65 (amino acids 1 to 306) and murine p65
(amino acids 1 to 364), respectively, in frame after the green
fluorescent protein (GFP) gene of EGFP-C3 (Invitrogen Corporation) in
the EcoRI and KpnI sites. EGFP-c-Rel,
EGFP-c-Rel(RHD), and EGFP-c-Rel(344) contain full-length murine c-Rel,
murine c-Rel (amino acids 1 to 297), mouse c-Rel (amino acids 1 to
344), respectively, in frame after GFP in the EcoRI and
BamHI sites. The fragment in EGFP-p65(NES4A) was generated
by PCR site-directed mutagenesis, with the four leucines at residues
434, 438, 441, and 443 changed to alanines and inserted in frame after
GFP at EcoRI and XhoI sites. pCDNA3.hCRM1 was
obtained by BamHI digestion of full-length human CRM1 cDNA
clone in pBS-hCRM1 (a gift from G. Grosveld). pERVF2.p50 contained the
full-length processed murine p50 (4), which was cloned
after the cytomegalovirus promoter in plasmid pERVF2. The sequences of
all plasmids used in this study were confirmed, and expression of
proteins was verified by Western blot analysis.
Transfections.
COS cell and BOSC23 cell transfection was
done by the calcium phosphate method as previously described
(32) or with Fugene-6 transfection reagent according to
the manufacturer's specifications (Roche Molecular Biochemicals).
Leptomycin B (LMB) (10 ng/ml), a generous gift from M. Yoshida
(University of Tokyo), was added 4 h prior to harvest.
Immunoprecipitation.
Cells were washed three times with
phosphate-buffered saline (PBS). Whole-cell extracts were made by
lysing the cells in TNT buffer (20 mM Tris-HCl [pH 7.5], 200 mM NaCl,
1% Triton X-100) with phosphatase and protease inhibitors. Then 100 µg of whole-cell extracts was incubated first with 30 µl of
prewashed protein A-agarose beads in a 50% slurry (Roche Molecular
Biochemicals) and then appropriate antibodies in TNT buffer with 0.1%
Triton X-100 for 4 h. Anti-I
B
, anti-c-Rel, and anti-p65
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz,
Calif.). The supernatants were subjected to secondary
immunoprecipitation as indicated in the figure legends. The
immunoprecipitates were washed three times with TNT buffer and eluted
with 4 × sodium dodecyl sulfate (SDS) buffer by heating at
100°C for 5 min. The supernatants were separated by SDS-10%
polyacrylamide gel electrophoresis (PAGE) for Western blot analysis.
Western blot analysis.
Polyacrylamide gels were transferred
to enhanced chemiluminescence Hybond nitrocellulose membrane
(Amersham). The membranes were blocked with 5% milk in TBST buffer and
then incubated with anti-c-Rel, anti-p65, or anti-I
B
at a
dilution of 1:500 for 1 h at room temperature. The membranes were
washed and incubated with peroxidase-conjugated anti-rabbit Ig
(Amersham) at a dilution of 1:2,000. The chemiluminescence signal was
detected using SuperSignal substrate according to the manufacturer's
specification (Pierce, Rockford, Ill.).
Immunostaining.
The procedures for immunostaining of
adherent cells were the same as described previously (42).
For staining suspension cells (T cells and B cells), the procedures
were described previously (8). Cells were allowed to
settle on UV-sterilized coverslips (Fisher) with or without
poly-L-lysine treatment (Sigma) overnight. LMB (100 ng/ml)
was added 45 min prior to the staining. Cells were fixed in 3%
paraformaldehyde for 20 min at room temperature and then permeabilized
with buffer WB (0.5% NP-40, 0.01% sodium azide in 1 × PBS). The
blocking was done with 5% normal donkey serum (Jackson Laboratory) at
room temperature for 30 min. After blocking, the cells were incubated
with primary antibodies in buffer WB with 5% normal donkey serum for
30 min at room temperature and then washed three times with buffer WB.
The secondary antibody, fluorescein isothiocyanate (FITC)-conjugated
anti-rabbit Ig (Jackson Laboratory) was used at a 1:300 dilution in WB
with 5% normal donkey serum for 30 min at room temperature. After
several washes 4',6'-diamidino-2-phenylindole (DAPI) (Molecular Probes,
Eugene, Oreg.) was used at 1 µg/ml for counterstaining the nucleus.
After further washing, the cells were mounted with ProLong Antifade (Molecular Probes) according to the manufacturer's specifications.
Fluorescence microscopy.
The subcellular localization of GFP
and the immunofluorescence signals were observed by fluorescence
microscopy (Axiophot II; Zeiss) with a GFP generic filter, FITC,
rhodamine, and DAPI filter.
 |
RESULTS |
Multiple factors contribute to cytosolic localization by
I
B
.
We have previously shown that I
B
contains an NES
in its N-terminal domain, and cytosolic localization of p65 by I
B
requires nuclear export. I
B
also contains another NES in its
C-terminal domain (1, 33, 37). To test whether these NESs
were the only mediators of cytoplasmic localization, GFP-Rel proteins
were coexpressed in COS cells with I
B
derivatives mutated in one or both NESs. GFP-p65 was entirely cytoplasmic in the presence of
wild-type I
B
or derivatives mutated at the N-terminal NES (NESn)
or both NESs (NESnc) (Fig. 1, top three
panels). The observed cytoplasmic location was the result of nuclear
export because treatment of the transfected cells with LMB led to
nuclear accumulation of both p65 and I
B
proteins (data not
shown). Therefore, neither known NES sequence in I
B
was essential
for cytoplasmic retention of p65. We conclude that other CRM1-dependent
export determinants were involved, which could lie within the ankyrin
domains of I
B
or in p65. Mutation of an NES in p65 identified by
Harhaj and Sun (14) resulted in mixed nuclear and
cytoplasmic distribution of the protein in the presence of
I
B
NESnc (Fig. 1B, top panel). Cytoplasmic expression of a complex
that lacks all three NESs was more clearly evident in a C-terminal
truncation mutant of p65, GFP-p65(364), which lacks the C-terminal NES.
This protein was located in the cytoplasm in the presence of
I
B
NESnc. We conclude that nuclear export is not the only
mechanism by which I
B
regulates the subcellular distribution of
p65.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 1.
Multiple determinants of cytosolic localization in
p65-I B protein complex. GFP-p65 and derivatives thereof were
expressed in COS cells with HA-I B (first row) or HA-I B
derivatives containing mutations at the N-terminal NES (NESn), or both
N- and C-terminal NESs (NESnc), as indicated. Thirty-six hours after
transfection, half of the cells were treated with LMB and fixed for
fluorescent visualization. Columns show GFP fluorescence, anti-HA
antibodies detected by rhodamine-coupled secondary antibody, and DAPI
staining, respectively. GFP-p65NES4A contains four alanine residues
replacing leucines in the C-terminal NES of p65; GFP-p65(RHD) contains
the first 306 amino acids of p65 that include the RHD and the NLS
(residues 301 to 304); GFP-p65(364) contains the first 364 amino acids
of p65. All p65 derivatives were coexpressed with the doubly mutated
I B NESnc. Cells were fixed for fluorescent visualization as
described in the text. Representative results are shown from one of
three independent experiments.
|
|
A fusion protein containing only the RHD of p65,
GFP-p65(RHD), was exclusively nuclear when coexpressed with
I

B

NESnc (Fig.
1B), but cytoplasmic in the presence of
wild-type I

B

(data not
shown). Colocalization of the I

B

derivatives with GFP-p65(RHD)
suggested that the proteins were
complexed (compare GFP and anti-HA
fluorescence in Fig.
1B, third
line); this was directly confirmed
by coimmunoprecipitation (data not
shown). Location of GFP-p65(364)
in the cytoplasm but GFP-p65(306) in
the nucleus when complexed
to I

B

NESnc suggested that I

B

interaction with residues beyond
the NLS of p65 (which is within the
RHD) attenuated NLS function.
Thus, the mutated I

B

compensated
for the attenuated NLS of GFP-p65(364)
but not the exposed NLS of
GFP-p65(RHD). These observations provide
the first functional evidence
for attenuation of the p65 NLS in
complex with I

B

. Use of an
export-deficient I

B

mutant was
key in distinguishing the relative
contributions of export and
import in the net subcellular distribution
of p65-I

B
complexes.
Unlike GFP-65, GFP-c-Rel showed a mixed distribution (nucleus plus
cytoplasm) in the presence of I

B

NESnc (Fig.
2, third
line). This pattern was similar
to the NES-mutated p65 derivative,
suggesting that c-Rel did not have
an NES in its C-terminal domain.
To directly compare CRM1
responsiveness of p65 and c-Rel, we coexpressed
GFP derivatives of
these proteins in BOSC23 cells together with
human CRM1 (hCRM1) (Fig.
3). Both proteins were predominantly
nuclear in the absence of CRM1; however, GFP-p65 but not
GFP-c-Rel
redistributed to the cytoplasm in the presence of
hCRM1. This
effect was mediated by the C-terminal NES of p65, because
point
mutations or deletion of this sequence made the protein
unresponsive
to hCRM1 (data not shown).

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
Multiple determinants of cytosolic localization in
c-Rel-I B protein complex. GFP-c-Rel and derivatives thereof were
transiently transfected with HA-I B (first row) or its derivative
nuclear export mutant NESn or NESnc as described in the legend to Fig.
1. GFP-c-Rel(RHD) contains the first 297 residues of c-Rel that include
the RHD and the NLS (residues 292 to 295). GFP-c-Rel(344) contains the
first 344 residues of c-Rel. Thirty-six hours after transfection, cells
were immunostained for fluorescent visualization. Results shown are
representative of at least three independent experiments.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
c-Rel does not contain a CRM1-dependent export sequence.
BOSC23 cells were transiently transfected with expression plasmids
encoding GFP-p65 or GFP-cRel proteins as indicated, with or without a
plasmid encoding full-length hCRM1. The total amount of DNA used in
transfections was normalized with empty vector. Thirty-six hours after
transfection, cells were fixed for DAPI staining and fluorescence
visualization. Results are from one of three independent experiments.
|
|
As observed with p65, the RHD of c-Rel, GFP-c-Rel(RHD), was exclusively
nuclear in the presence of I

B

NESnc, but a longer
derivative had
considerable cytoplasmic expression (Fig.
2B).
Our interpretation is
that the NLS of c-Rel(344) is attenuated
by interaction with I

B

,
but that of the RHD is not. We conclude
that p65 and c-Rel are similar
to the extent that both NLSs are
attenuated in association with
I

B

; they are different in that
p65 contains a C-terminal NES, but
c-Rel does not. The biological
implications of the differences are
discussed
below.
Effects of heterodimerization.
The major cellular Rel-DNA
complexes detected by mobility shift assays contain heterodimers of p65
or c-Rel with p50 or p52 (27, 30). To explore how the
subunit composition of the Rel dimer affected subcellular localization,
we coexpressed GFP-p65 or GFP-c-Rel with p50 and I
B
. The
GFP-p65-p50 heterodimer was located in the cytoplasm in the presence
of either wild-type I
B
(data not shown) or I
B
NESn (Fig.
4). Mutation of the p65 NES did not
affect the cytosolic location of the p65-p50 complex in the presence of
wild-type I
B
(data not shown), but resulted in nuclear
localization of the I
B
NESn-conaining heterotrimer (Fig. 4, fourth
and fifth columns, second row).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Increased nuclear propensity of p50-c-Rel heterodimers.
Left panels show the subcellular distribution of homodimers of GFP-p65
(first row), an NES-mutated GFP-p65 (second row), and GFP-c-Rel (third
row) in the presence of HA-I B NESn (I B mutated in the
N-terminal NES). Right panels show the distribution of heterodimers of
these Rel proteins together with p50 in the presence of
HA-I B NESn. In all cases, GFP fluorescence colocalized with
anti-HA, indicating that I B was associated with the Rel homo- or
heterodimers. All complexes were predominantly nuclear when the cells
were treated with LMB for the last 3 h prior to harvest (data not
shown). Results shown are from one of three independent experiments.
|
|
All cytosolic complexes moved to the nucleus when the cells were
treated with LMB (data not shown), indicating that export
was necessary
to maintain NF-

B in the cytosol. Nuclear location
of p50-p65NES
heterodimers (Fig.
4, fourth column, second row)
but not p65NES
homodimers (Fig.
4, first column, second row) complexed
to I

B

NESn
suggested that the p50 NLS was more effective at directing
nuclear
entry than the attenuated p65 NLS in an I

B

-containing
complex. We
conclude that the p50 NLS is active in an NF-

B-I

B
complex and
that cytosolic location of the complex requires ongoing
nuclear
export.
The data in Fig.
2 and
3 showed that c-Rel does not contain an NES.
Consistent with this, GFP-c-Rel-p50 complexes were retained
in the
cytoplasm by wild-type I

B

(data not shown), but not I

B

NESn
(Fig.
4, third row). Because c-Rel homodimers were brought to
the
cytoplasm by I

B

NESn, the nuclear location of p50-c-Rel
heterodimers
(Fig.
4, fourth column, third row) is most likely because
the
NLS of p50 is exposed in this complex. These observations suggest
that various Rel homo- and heterodimers exhibit a hierarchy in
their
preference to be located in the cytoplasm when complexed
to I

B

.
At one extreme, the (p65)
2-I

B

complex contains three
NESs, which allows it to be removed most efficiently from the
nucleus,
while the p50-c-Rel-I

B

complex contains only one NES,
making it
more likely to be nuclear. As shown below, this may
be, in part, the
explanation for the preferential location of
p50-c-Rel complexes in
the nuclei of B cells. Conversely, the
propensity for nuclear export
may define the ordered removal of
Rel complexes from the nucleus
at the end of cell
stimulation.
Rel complexes in lymphocytes.
From the studies described
above, we drew two conclusions: first, that p65 and c-Rel differed in
that p65 contained an NES while c-Rel did not, and second, that
heterodimerization with p50 favored nuclear localization because its
NLS was active when complexed to I
B
. We propose that the subunit
specificity of p50-c-Rel complexes in B-cell nuclei may be a
consequence of inefficient export of this complex from the nucleus
compared to p65-containing complexes. B-cell specificity of the
phenomenon is a consequence of c-Rel association with I
B
only in
B cells (see below); this leads to increased c-Rel in the nucleus as it
shuttles with I
B
and because I
B
is degraded more rapidly.
To identify c-Rel-associated I

Bs, we carried out
immunoprecipitations followed by immunoblotting. Whole-cell extracts
from
the indicated cells were immunoprecipitated with only one antibody
or sequentially with two antibodies. The precipitates were fractionated
by SDS-PAGE and immunoblotted with anti-c-Rel or anti-p65 antibodies.
Anti-I

B

coprecipitated c-Rel only from A20 (mature) B cells,
but
not from 70Z (pre-B) cells or D5h3 (T hybridoma) cells (Fig.
5A, left
panels, lane 2). In contrast, c-Rel-I

B

association
was detected
in all these cell extracts (Fig.
5A, lane 4). Furthermore,
preclearing
the extracts with anti-I

B

removed all the c-Rel
from 70Z and D5h3
extracts, confirming that there was an insignificant
amount of
I

B

-associated c-Rel in these cells (Fig.
5A, lane
5). Conversely,
preclearing with anti-I

B

reduced the residual
I

B

-associated
c-Rel only in A20 extracts (Fig.
5A, lane 3).
These observations
indicate that c-Rel only associates with I

B
in mature B cells.
Unlike c-Rel, endogenous p65 was associated
with both I

B

and
I

B

in all three cell lines (Fig.
5A, right
panels).


View larger version (36K):
[in this window]
[in a new window]
|
FIG. 5.
c-Rel associates with I B in mature B cells but not
in pre-B cells and mature T cells. (A) Whole-cell extracts (100 µg)
from mature B cells (A20), pre-B cells (70Z), or mature T cells (D5h3)
were immunoprecipitated with nonspecific IgG (lane 1), anti-I B
antibody (lane 2), or anti-I B antibody (lane 4). For sequential
immunoprecipitation, extracts were precleared with the first antibody
and immunoprecipitated with the second antibody, as indicated above the
lanes (lanes 3 and 5). Immunoprecipitates were separated by SDS-PAGE,
and Rel proteins associated with I Bs were detected by
immunoblotting. Left panel shows the results using anti-c-Rel and
anti-I B antibodies (Ab) to probe the blots; right panel was
probed with anti-p65 and anti-I B antibodies. I B protein was
not assayed for because it comigrated with the Ig heavy-chain protein
used for immunoprecipitation. Results are representative of at least
three independent experiments. (B) Whole-cell extracts from indicated
cells were analyzed by immunoprecipitation using nonspecific IgG (lane
1), anti-I B (lane 2), and anti-I B (lane 3), followed by
immunoblotting as described above. For each cell type, the upper panel
shows the results using anti-c-Rel antibodies to probe the blots, and
the lower panel shows the results of probing with anti-p65 antibodies.
Top three rows correspond to cell lines representing pre-B, mature B,
and T cells. Bottom row shows the analysis of primary splenic B and T
cells purified as described in the text. Results are representative of
at least two independent experiments with each cell type.
|
|
We further confirmed this trend in additional cell lines. In these
studies, anti-I

B

or anti-I

B

was used for
immunoprecipitation.
I

B-associated proteins were fractionated by
SDS-PAGE, and c-Rel
or p65 was detected by immunoblotting.
I

B

-associated p65 was
detected in six additional cell lines
tested representing pre-B,
mature B, and mature T cells (Fig.
5B, top
three panels, lanes
2 and 5), as well as primary splenic B and T cells
(Fig.
5B, bottom
panel). Anti-I

B

also coprecipitated both c-Rel
and p65 from
all cells examined (Fig.
5B, lanes 3 and 6). However,
I

B

-associated
c-Rel was only detected in mature B-cell lines and
in splenic
B cells (Fig.
5B, second and fourth rows, lanes 2 and 5),
but
not in pre-B, mature T, or splenic T cells. Taken together with
the
results in Fig.
5A, these observations suggest that c-Rel-I

B
complexes are a unique feature of mature B
lymphocytes.
The proposed model makes the additional prediction that p65 shuttles
between the nucleus and the cytoplasm in most cells because
it is
associated with I

B

, while c-Rel shuttles only in B cells.
We
tested this prediction using LMB to block CRM1-dependent export
in the
three cell lines used in Fig.
5A. Endogenous p65 was predominantly
cytoplasmic in all three cell lines prior to treatment with LMB
(Fig.
6A, left panels). In the presence of LMB,
nuclear translocation
of p65 was evident from its mixed nuclear and
cytoplasmic distribution
in all cells (Fig.
6A, right panels). The
partial redistribution
of p65 was probably because only a fraction of
the total cytoplasmic
pool of p65 was associated with I

B

; the
rest that was associated
with other I

Bs did not shuttle, and
therefore its subcellular
location did not change with LMB.
Immunostaining with anti-I

B
and anti-I

B

antibodies
confirmed that only I

B

redistributed
to the nucleus in response
to LMB treatment of these cells (data
not shown). Unlike p65, the
predominantly cytoplasmic distribution
of c-Rel in untreated cells was
only altered in A20 cells after
LMB treatment (Fig.
6B). Note that the
constitutively nuclear
c-Rel in A20 cells is difficult to discern in
these figures because
the majority of the protein, and consequently the
imunofluorescence,
is located in the cytoplasm. We conclude that the
subcellular
location of c-Rel in B cells is regulated by competing
nuclear
import and export. In contrast, c-Rel in other cell types is
sequestered
in the cytoplasm by I

B

or I

B

.


View larger version (70K):
[in this window]
[in a new window]
|
FIG. 6.
c-Rel shuttles only in mature B cells. A20, D5h3, and
70Z cells were settled on poly-L-lysine-coated coverslips
overnight. Half of the coverslips with attached cells were treated with
LMB (100 ng/ml) for 45 min. Cells with and without LMB treatment were
fixed and permeabilized for immunostaining with anti-p65 antibodies (A)
or anti-c-Rel antibodies (B). Green fluorescence in the first and the
third columns shows endogenous p65 (A) and endogenous c-Rel (B) of A20
(top row), 70Z (second row), and D5h3 (third row) cells before and
after LMB treatment as indicated. Blue fluorescence in the second and
fourth columns shows DAPI staining of nuclei. Results shown are from
one of three independent experiments.
|
|
 |
DISCUSSION |
We extended our earlier studies of nuclear-cytoplasmic dynamics of
Rel-I
B proteins to (i) compare the contribution of Rel proteins to
export-dependent cytoplasmic localization and (ii) study the effects of
heterodimerization on subcellular distribution. Our observations lead
to a mechanism for the constitutive presence of nuclear p50-c-Rel
heterodimers in B lymphocytes. The crux of our model is that
inefficient export of p50-c-Rel heterodimers from B-cell nuclei may
lead to accumulation of this protein in the nucleus. Why does this only
happen in B cells, and what determines subunit specificity? We found
that c-Rel is mainly associated with I
B
in non-B cells. The slow
turnover rate of I
B
and its lack of nucleocytoplasmic shuttling
ensure that this c-Rel rarely enters the nucleus.
In contrast, I
B
-associated c-Rel in mature B cells can reach the
nucleus in two ways. First, there is continuous generation of free p65
and c-Rel (homo- and p50-containing heterodimers) due to the higher
turnover rate of I
B
. These proteins translocate to the nucleus,
from which they must be exported to maintain the cytoplasmic pool. This
must be mediated by I
B
, since the other I
Bs do not have export
potential. Newly synthesized I
B
that migrates to the nucleus
finds a DNA-binding competent pool of Rel homo- and heterodimers with
which to associate. We propose that the absence of an NES in c-Rel is
manifest at this stage, and c-Rel is exported out of the nucleus less
efficiently than p65. Association with p50 further enhances nuclear
propensity of p50-c-Rel heterodimers because the p50 NLS is not
attenuated by I
B
. The proposed discrimination based on efficiency
of export suggests that export capacity is limiting under these
conditions. At present we cannot distinguish whether the limitation is
at the level of the export machinery or the export chaperone I
B
. Second, I
B
-associated c-Rel also enters the nucleus,
because the complexes shuttle. Once in the nucleus, some of these
complexes may dissociate if, for example, export is limiting and the
intact complex is not rapidly removed. Again, the reduced export
potential of c-Rel-containing complexes compared to p65-containing
complexes would skew the subunit composition of the resulting
DNA-binding activity towards c-Rel. Thus, B-cell-specific nuclear
NF-
B is the dynamic consequence of the combined properties of
Rel, I
B, and cellular export proteins.
Antibody accessibility studies had first led to the model that
cytoplasmic retention of NF-
B by I
Bs was the result of hiding the
NLSs present on the Rel proteins (45). While this may be true for I
B
and I
B
(43), it is clear that
functional NLS activity is present in Rel-I
B
complexes, which
undergo nucleocytoplasmic shuttling. Moreover, the finding that
I
B
-dependent nuclear export is the major mechanism of cytoplasmic
"retention" by I
B
circumvents the necessity to hide NLSs in
Rel-I
B
complexes. This raises the question of whether association
with I
B
affects the NLS of Rel proteins at all.
The crystal structure of the NF-
B-I
B
complex shows that
I
B
is oriented such that the first two ankyrin domains contact the C terminus of the RHDs of p65 and p50 (17, 18). This
interaction forces a 19-amino-acid stretch of p65 that contains the NLS
into two
-helices (18). The NLS is located at the end
of the first helix, and three of its side chains make salt bridges with
I
B
. The close association of I
B
and the p65 NLS is
consistent with inactivation or attenuation of NLS function. The NLS of
p50 does not contact I
B
, leading to the speculation that it may
be occluded indirectly to keep the p50-p65 complex in the cytoplasm
(5).
We provide the first functional evidence that the NLSs of both p65 and
c-Rel are attenuated by association with I
B
. This conclusion
follows from the observation that the RHDs of p65 and c-Rel were
nuclear in the presence of an NES-mutated I
B
derivative, whereas
longer Rel proteins were located in the cytoplasm. Use of the
NES-mutated I
B
in these studies was essential to distinguish export- from import-dependent cytoplasmic location. Because export did
not play a role in the subcellular distribution of these complexes, our
interpretation is that the nuclear import potential of longer Rel
proteins is reduced when they are complexed to I
B
. This is most
likely due to the secondary structure that is induced in the p65 NLS by
I
B
when residues beyond the RHD are present (18).
Recent biochemical studies also show that these additional residues
contribute to I
B
binding to p65 (35).
We also present evidence that the p50 NLS is functionally available and
mediates nuclear entry of p50-p65-I
B
and p50-c-Rel-I
B
complexes. These observations offer no evidence for "indirect" occlusion of the p50 NLS. Rather, cytoplasmic location of the heterodimers must involve compensation of the p50 NLS by the export potential of the I
B
NES. In other studies we have found that the
p65 NES is weaker than the I
B
NES (W. Tam, unpublished
observations). This makes good sense because a strong NES in p65 would
make this protein constitutively cytoplasmic even in the absence of
I
B
. Instead, the weaker NES accentuates nuclear exit in the
presence of I
B
, but is dominated by the unattenuated NLS in the
absence of I
B
. Modulating the strength of NESs and NLSs in Rel
and I
B family members presumably allows the appropriate balance of
nuclear and cytoplasmic expression of NF-
B proteins.
Our observations indicate a hierarchy of nuclear propensity among Rel
homo- and heterodimers which is based on the presence or absence of
NESs and association with p50. For example, p65 homodimers contain two
NESs and two unattenuated NLSs; (p65)2 complexes are
predominantly nuclear because the NLSs dominate. Association with
I
B
attenuates the NLSs and adds an additional NES; the result is
location in the cytoplasm. Compared to p65, c-Rel has a greater
tendency to be nuclear because it lacks a well-defined NES. Association
with p50 further accentuates this by providing an NLS that is active
even when complexed to I
B
. As described above, one consequence of
this hierarchy is to enrich c-Rel-p50 complexes in B-cell nuclei. We
speculate that this hierarchy may also dictate the efficiency by which
Rel proteins are removed from the nucleus at the end of cell
stimulation. Accordingly, p65 homodimers would be removed most
efficiently, followed by c-Rel homodimers, followed by p50-p65 and
p50-c-Rel heterodimers. One reason may be that the most potent
transcription activator must be downregulated effectively for the cell
to reach its resting state.
 |
ACKNOWLEDGMENTS |
The human CRM1 gene and LMB were kindly provided by G. Grosveld
and M. Yoshida (University of Tokyo), respectively. We thank Phil
Gnatowski for help in preparation of the manuscript.
This work was supported by NIH grant AI-41035 to R.S.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Rosenstiel Basic
Medical Sciences Research Center and Department of Biology, Brandeis University, Waltham, MA 02454. Phone: (781) 736-2454. Fax: (781) 736-2405. E-mail: sen{at}brandeis.edu.
Present address: Massachusetts General Hospital Cancer Center and
Harvard Medical School, Charlestown, MA 02129.
 |
REFERENCES |
| 1.
|
Arenzana-Seisdedos, F.,
P. Turpin,
M. Rodriguez,
D. Thomas,
R. T. Hay,
J. L. Virelizier, and C. Dargemont.
1997.
Nuclear localization of I B promotes active transport of NF- B from the nucleus to the cytoplasm.
J. Cell Sci.
110:369-378[Abstract].
|
| 2.
|
Bajpai, U. D.,
K. Zhang,
M. Teutsch,
R. Sen, and H. H. Wortis.
2000.
Bruton's tyrosine kinase links the B cell receptor to nuclear factor B activation.
J. Exp. Med.
191:1735-1744[Abstract/Free Full Text].
|
| 3.
|
Beg, A. A.,
W. C. Sha,
R. T. Bronson, and D. Baltimore.
1995.
Constitutive NF- B activation, enhanced granulopoiesis, and neonatal lethality in I B -deficient mice.
Genes Dev.
9:2736-2746[Abstract/Free Full Text].
|
| 4.
|
Blank, V.,
P. Kourilsky, and A. Israel.
1991.
Cytoplasmic retention, DNA binding and processing of the NF- B p50 precursor are controlled by a small region in its C-terminus.
EMBO J.
10:4159-4167[Medline].
|
| 5.
|
Cramer, P., and C. W. Muller.
1999.
A firm hand on NF B: structures of the I B -NF B complex.
Structure Fold Des.
7:R1-R6[Medline].
|
| 6.
|
Doerre, S., and R. B. Corley.
1999.
Constitutive nuclear translocation of NF- B in B cells in the absence of I B degradation.
J. Immunol.
163:269-277[Abstract/Free Full Text].
|
| 7.
|
Ellmeier, W.,
S. Jung,
M. J. Sunshine,
F. Hatam,
Y. Xu,
D. Baltimore,
H. Mano, and D. R. Littman.
2000.
Severe B cell deficiency in mice lacking the Tec kinase family members Tec and Btk.
J. Exp. Med.
192:1611-1624[Abstract/Free Full Text].
|
| 8.
|
Feske, S.,
R. Draeger,
H. H. Peter,
K. Eichmann, and A. Rao.
2000.
The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells.
J. Immunol.
165:297-305[Abstract/Free Full Text].
|
| 9.
|
Fields, E. R.,
B. J. Seufzer,
E. M. Oltz, and S. Miyamoto.
2000.
A switch in distinct I B degradation mechanisms mediates constitutive NF- B activation in mature B cells.
J. Immunol.
164:4762-4767[Abstract/Free Full Text].
|
| 10.
|
Gerondakis, S.,
A. Strasser,
D. Metcalf,
G. Grigoriadis,
J. Y. Scheerlinck, and R. J. Grumont.
1996.
Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Proc. Natl. Acad. Sci. USA
93:3405-3409[Abstract/Free Full Text].
|
| 11.
|
Grossmann, M.,
Y. Nakamura,
R. Grumont, and S. Gerondakis.
1999.
New insights into the roles of Rel/NF B transcription factors in immune function, hemopoiesis and human disease.
Int. J. Biochem. Cell Biol.
31:1209-1219[CrossRef][Medline].
|
| 12.
|
Grossmann, M.,
L. A. O'Reilly,
R. Gugasyan,
A. Strasser,
J. M. Adams, and S. Gerondakis.
2000.
The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
EMBO J.
19:6351-6360[CrossRef][Medline].
|
| 13.
|
Grumont, R. J., and S. Gerondakis.
1994.
The subunit composition of NF- B complexes changes during B-cell development.
Cell Growth Differ.
5:1321-1331[Abstract].
|
| 14.
|
Harhaj, E. W., and S. C. Sun.
1999.
Regulation of RelA subcellular localization by a putative nuclear export signal and p50.
Mol. Cell. Biol.
19:7088-7095[Abstract/Free Full Text].
|
| 15.
|
Hay, R. T.,
L. Vuillard,
J. M. Desterro, and M. S. Rodriguez.
1999.
Control of NF- B transcriptional activation by signal induced proteolysis of I B .
Phil. Trans. R. Soc. Lond. B Biol. Sci.
354:1601-1609[Abstract/Free Full Text].
|
| 16.
|
Huang, T. T.,
N. Kudo,
M. Yoshida, and S. Miyamoto.
2000.
A nuclear export signal in the N-terminal regulatory domain of I B controls cytoplasmic localization of inactive NF- B/I B complexes.
Proc. Natl. Acad. Sci. USA
97:1014-1019[Abstract/Free Full Text].
|
| 17.
|
Huxford, T.,
D. B. Huang,
S. Malek, and G. Ghosh.
1998.
The crystal structure of the I B /NF- B complex reveals mechanisms of NF- B inactivation.
Cell
95:759-770[CrossRef][Medline].
|
| 18.
|
Jacobs, M. D., and S. C. Harrison.
1998.
Structure of an I B /NF- B complex.
Cell
95:749-758[CrossRef][Medline].
|
| 19.
|
Johnson, C.,
D. Van Antwerp, and T. J. Hope.
1999.
An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of I B
EMBO J.
18:6682-6693[CrossRef][Medline].
|
| 20.
|
Kerner, J. D.,
M. W. Appleby,
R. N. Mohr,
S. Chien,
D. J. Rawlings,
C. R. Maliszewski,
O. N. Witte, and R. M. Perlmutter.
1995.
Impaired expansion of mouse B cell progenitors lacking Btk.
Immunity
3:301-312[CrossRef][Medline].
|
| 21.
|
Khan, W. N.,
F. W. Alt,
R. M. Gerstein,
B. A. Malynn,
I. Larsson,
G. Rathbun,
L. Davidson,
S. Muller,
A. B. Kantor,
L. A. Herzenberg, et al.
1995.
Defective B cell development and function in Btk-deficient mice.
Immunity
3:283-299[CrossRef][Medline].
|
| 22.
|
Kistler, B.,
A. Rolink,
R. Marienfeld,
M. Neumann, and T. Wirth.
1998.
Induction of nuclear factor- B during primary B cell differentiation.
J. Immunol.
160:2308-2317[Abstract/Free Full Text].
|
| 23.
|
Klaus, G. G.,
M. Holman,
C. Johnson-Leger,
C. Elgueta-Karstegl, and C. Atkins.
1997.
A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
Eur. J. Immunol.
27:2749-2756[Medline].
|
| 24.
|
Klement, J. F.,
N. R. Rice,
B. D. Car,
S. J. Abbondanzo,
G. D. Powers,
P. H. Bhatt,
C. H. Chen,
C. A. Rosen, and C. L. Stewart.
1996.
I B deficiency results in a sustained NF- B response and severe widespread dermatitis in mice.
Mol. Cell. Biol.
16:2341-2349[Abstract].
|
| 25.
|
Krappmann, D., and C. Scheidereit.
1997.
Regulation of NF- B activity by I B and I B stability.
Immunobiology
198:3-13[Medline].
|
| 26.
|
Liou, H. C.,
Z. Jin,
J. Tumang,
S. Andjelic,
K. A. Smith, and M. L. Liou.
1999.
c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function.
Int. Immunol.
11:361-371[Abstract/Free Full Text].
|
| 27.
|
Liou, H. C.,
W. C. Sha,
M. L. Scott, and D. Baltimore.
1994.
Sequential induction of NF- B/Rel family proteins during B-cell terminal differentiation.
Mol. Cell. Biol.
14:5349-5359[Abstract/Free Full Text].
|
| 28.
|
May, M. J., and S. Ghosh.
1997.
Rel/NF- B and I B proteins: an overview.
Semin. Cancer Biol.
8:63-73[CrossRef][Medline].
|
| 29.
|
Miyamoto, S.,
P. J. Chiao, and I. M. Verma.
1994.
Enhanced I B degradation is responsible for constitutive NF- B activity in mature murine B-cell lines.
Mol. Cell. Biol.
14:3276-3282[Abstract/Free Full Text].
|
| 30.
|
Miyamoto, S.,
M. J. Schmitt, and I. M. Verma.
1994.
Qualitative changes in the subunit composition of B-binding complexes during murine B-cell differentiation.
Proc. Natl. Acad. Sci. USA
91:5056-5060[Abstract/Free Full Text].
|
| 31.
|
Miyamoto, S.,
B. J. Seufzer, and S. D. Shumway.
1998.
Novel I B proteolytic pathway in WEHI231 immature B cells.
Mol. Cell. Biol.
18:19-29[Abstract/Free Full Text].
|
| 32.
|
Nelsen, B.,
G. Tian,
B. Erman,
J. Gregoire,
R. Maki,
B. Graves, and R. Sen.
1993.
Regulation of lymphoid-specific immunoglobulin µ heavy chain gene enhancer by ETS-domain proteins.
Science
261:82-86[Abstract/Free Full Text].
|
| 33.
|
Ossareh-Nazari, B.,
F. Bachelerie, and C. Dargemont.
1997.
Evidence for a role of CRM1 in signal-mediated nuclear protein export.
Science
278:141-144[Abstract/Free Full Text].
|
| 34.
|
Pahl, H. L.
1999.
Activators and target genes of Rel/NF- B transcription factors.
Oncogene
18:6853-6866[CrossRef][Medline].
|
| 35.
|
Phelps, C. B.,
L. L. Sengchanthalangsy,
T. Huxford, and G. Ghosh.
2000.
Mechanism of I B binding to NF- B dimers.
J. Biol. Chem.
275:29840-29846[Abstract/Free Full Text].
|
| 36.
|
Phillips, R. J., and S. Ghosh.
1997.
Regulation of I B in WEHI 231 mature B cells.
Mol. Cell. Biol.
17:4390-4396[Abstract].
|
| 37.
|
Prigent, M.,
I. Barlat,
H. Langen, and C. Dargemont.
2000.
I B and I B /NF- B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2.
J. Biol. Chem.
275:36441-36449[Abstract/Free Full Text].
|
| 38.
|
Satterthwaite, A. B.,
Z. Li, and O. N. Witte.
1998.
Btk function in B cell development and response.
Semin. Immunol.
10:309-316[CrossRef][Medline].
|
| 39.
|
Sha, W. C.,
H. C. Liou,
E. I. Tuomanen, and D. Baltimore.
1995.
Targeted disruption of the p50 subunit of NF- B leads to multifocal defects in immune responses.
Cell
80:321-330[CrossRef][Medline].
|
| 40.
|
Shumway, S. D.,
M. Maki, and S. Miyamoto.
1999.
The PEST domain of I B is necessary and sufficient for in vitro degradation by µ-calpain.
J. Biol. Chem.
274:30874-30881[Abstract/Free Full Text].
|
| 41.
|
Snapper, C. M.,
P. Zelazowski,
F. R. Rosas,
M. R. Kehry,
M. Tian,
D. Baltimore, and W. C. Sha.
1996.
B cells from p50/NF- B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.
J. Immunol.
156:183-191[Abstract].
|
| 42.
|
Tam, W. F.,
L. H. Lee,
L. Davis, and R. Sen.
2000.
Cytoplasmic sequestration of Rel proteins by I B requires CRM1-dependent nuclear export.
Mol. Cell. Biol.
20:2269-2284[Abstract/Free Full Text].
|
| 43.
|
Tam, W. F., and R. Sen.
2001.
I B family member function by different mechanisms.
J. Biol. Chem.
276:7701-7704[Abstract/Free Full Text].
|
| 44.
|
Whiteside, S. T., and A. Israel.
1997.
I B proteins: structure, function and regulation.
Semin. Cancer Biol.
8:75-82[CrossRef][Medline].
|
| 45.
|
Zabel, U.,
T. Henkel,
M. S. Silva, and P. A. Baeuerle.
1993.
Nuclear uptake control of NF- B by MAD-3, an I B protein present in the nucleus.
EMBO J.
12:201-211[Medline].
|
Molecular and Cellular Biology, July 2001, p. 4837-4846, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4837-4846.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Williams, J. L., Ji, P., Ouyang, N., Liu, X., Rigas, B.
(2008). NO-donating aspirin inhibits the activation of NF-{kappa}B in human cancer cell lines and Min mice. Carcinogenesis
29: 390-397
[Abstract]
[Full Text]
-
Mittal, A., Papa, S., Franzoso, G., Sen, R.
(2006). NF-{kappa}B-Dependent Regulation of the Timing of Activation-Induced Cell Death of T Lymphocytes. J. Immunol.
176: 2183-2189
[Abstract]
[Full Text]
-
Sasaki, C. Y., Barberi, T. J., Ghosh, P., Longo, D. L.
(2005). Phosphorylation of RelA/p65 on Serine 536 Defines an I{kappa}B{alpha}-independent NF-{kappa}B Pathway. J. Biol. Chem.
280: 34538-34547
[Abstract]
[Full Text]
-
Hachem, A., Gartenhaus, R. B.
(2005). Oncogenes as molecular targets in lymphoma. Blood
106: 1911-1923
[Full Text]
-
Prendes, M., Zheng, Y., Beg, A. A.
(2003). Regulation of Developing B Cell Survival by RelA-Containing NF-{kappa}B Complexes. J. Immunol.
171: 3963-3969
[Abstract]
[Full Text]
-
Liu, J., Beller, D. I.
(2003). Distinct Pathways for NF-{kappa}B Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains. J. Immunol.
170: 4489-4496
[Abstract]
[Full Text]
-
Antonsson, A., Hughes, K., Edin, S., Grundstrom, T.
(2003). Regulation of c-Rel Nuclear Localization by Binding of Ca2+/Calmodulin. Mol. Cell. Biol.
23: 1418-1427
[Abstract]
[Full Text]
-
Kiernan, R., Bres, V., Ng, R. W. M., Coudart, M.-P., El Messaoudi, S., Sardet, C., Jin, D.-Y., Emiliani, S., Benkirane, M.
(2003). Post-activation Turn-off of NF-kappa B-dependent Transcription Is Regulated by Acetylation of p65. J. Biol. Chem.
278: 2758-2766
[Abstract]
[Full Text]
-
Knuefermann, P., Chen, P., Misra, A., Shi, S.-P., Abdellatif, M., Sivasubramanian, N.
(2002). Myotrophin/V-1, a Protein Up-regulated in the Failing Human Heart and in Postnatal Cerebellum, Converts NFkappa B p50-p65 Heterodimers to p50-p50 and p65-p65 Homodimers. J. Biol. Chem.
277: 23888-23897
[Abstract]
[Full Text]